Global Drugs For Immunotherapy Market Share, Growth, Drivers, Price, And Key Manufacturers | F. Hoffmann-La Roche Ltd., Novartis AG, Amgen, Inc., AbbVie, Inc., and Merck & Co. Inc.

The Drugs For Immunotherapy Global Market Report 2023 by The Business Research Company, provides drugs for immunotherapy market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Drugs For Immunotherapy Market:

In accordance with The Business Research Company’s illuminating Drugs For Immunotherapy Global Market Report of 2023, it is noteworthy that the expansive landscape of the global drugs for immunotherapy market exhibited remarkable growth, ascending from $208.56 billion in 2022 to a formidable $231.12 billion in 2023, boasting an impressive compound annual growth rate (CAGR) of 10.8%. Nevertheless, amidst this financial narrative, the specter of the Russia-Ukraine conflict looms large, casting a shadow upon the prospects of worldwide economic recuperation from the tumultuous throes of the COVID-19 pandemic, particularly in the near term.

The geopolitical tensions resulting from the Russia-Ukraine war have given rise to a cascade of repercussions, including the imposition of economic sanctions on various nations, a discernible surge in commodity prices, and consequential disruptions within global supply chains. These multifaceted developments have, in turn, precipitated a pervasive inflationary impact across diverse sectors encompassing goods and services, thereby exerting palpable ramifications on myriad markets worldwide. Against this backdrop, the trajectory of the global drugs for immunotherapy market is anticipated to persist in its ascension, culminating in a projected market size of $349.53 billion in 2027, marked by a commendable CAGR of 10.9%.

The drugs for immunotherapy market is being driven by rising incidences of cancer globally. The major causes of most cancers include obesity, smoking, alcohol, and improper eating habits.

Get A Free Sample Of The Report (Includes Graphs And Tables):

The drugs for immunotherapy market is segmented:
1) By Type: Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types
2) By Therapy Area: Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas
3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users

Top 5 Major Players:

Nonetheless, a significant impediment to the unfettered growth of the drugs for immunotherapy market lies in the prohibitive cost associated with these therapeutic interventions. Acting as a constraining factor, the exorbitant price tags attached to immunotherapy drugs present a formidable financial barrier, rendering the treatment inaccessible to a substantial cohort of patients. This financial encumbrance stems from the bespoke nature of immunotherapy drugs, tailored to the unique biological profiles of individual patients, coupled with the substantial investment costs incurred in their extensive research and development. To illustrate, paradigmatic examples such as Novartis’ Kymriah and Gilead Sciences’ Yescarta command a price range of $373,000 to $475,000 per patient, contingent upon the specific cancer type. Additionally, Bristol-Myers Squibb’s Yervoy, designated for the treatment of melanoma, a variant of skin cancer, entails a noteworthy cost of $120,000 per course of treatment. This prohibitive expense paradigm thus represents a formidable barrier to market accessibility, potentially impeding the trajectory of the drugs for immunotherapy market.

The drugs for immunotherapy market report table of contents includes:
1. Executive Summary
2. Drugs for Immunotherapy Market Characteristics
3. Drugs for Immunotherapy Market Trends And Strategies
4. Drugs for Immunotherapy Market – Macro Economic Scenario
5. Drugs for Immunotherapy Market Size And Growth


26. Africa Drugs for Immunotherapy Market
27. Drugs for Immunotherapy Market Competitive Landscape And Company Profiles
28. Drugs for Immunotherapy Pipeline Analysis
29. Key Mergers And Acquisitions In The Drugs for Immunotherapy Market
30. Drugs for Immunotherapy Market Future Outlook and Potential Analysis

List of Tables:
Table 1: Global Historic Market Growth, 2017-2022, $ Billion
Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3: Global Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4: Global Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5: Global Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion


Table 65: F. Hoffmann-La Roche Ltd Financial Performance
Table 66: Novartis AG Financial Performance
Table 67: Amgen, Inc Financial Performance
Table 68: AbbVie, Inc Financial Performance
Table 69: Merck & Co., Inc Financial Performance

Related Reports:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
Healthcare Blog:
Global Market Model: